Monika Kallubai Selected Research

3- rhamnopyranosyl(1- 4)- glucopyranosyl- 12- diacetoxy- 20- hydroxywitha- 5,24- dienolide

3/2021	Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives.
1/2018	Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monika Kallubai Research Topics

Disease

2	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 03/2021
2	Neoplasms (Cancer) 02/2019 - 04/2015
1	Neuroblastoma 10/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2020
1	Breast Neoplasms (Breast Cancer) 02/2019
1	Inflammation (Inflammations) 01/2018
1	Rheumatic Diseases (Rheumatism) 01/2018

Drug/Important Bio-Agent (IBA)

2	withanoside IVIBA 03/2021 - 01/2018
2	withanolide BIBA 03/2021 - 01/2018
2	withanoside VIBA 03/2021 - 01/2018
2	3- rhamnopyranosyl(1- 4)- glucopyranosyl- 12- diacetoxy- 20- hydroxywitha- 5,24- dienolideIBA 03/2021 - 01/2018
1	Pharmaceutical PreparationsIBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 03/2021
1	Human Serum Albumin FDA LinkGeneric 10/2020
1	swertiamarinIBA 10/2020
1	Glycoproteins (Glycoprotein)IBA 10/2020
1	UridineIBA 04/2020
1	Biological ProductsIBA 02/2019
1	SteroidsIBA 02/2019
1	Acetates (Acetic Acid Esters)FDA Link 02/2019
1	AshwagandhaIBA 01/2018
1	TriterpenesIBA 04/2015
1	lupeolIBA 04/2015